Scholar Rock Holding Corporation

Last updated September 27, 2026

Organization details

Legal name
Scholar Rock Holding Corporation
Ownership
Public
Status
Active
SIC code
2836 — Biological Products, (No Diagnostic Substances)
Jurisdiction of incorporation
Delaware
Headquarters city
Cambridge
Headquarters state / province
Massachusetts
Headquarters country
United States
Fiscal year end
December
Ticker symbol
SRRK
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001727196
EIN
82-3750435

Board of directors

Chief executives

Jay T. Backstrom · CHIEF EXECUTIVE OFFICER
Dates unknown
David Hallal · Chief Executive Officer
Dates unknown

Director election results

Annual meeting of June 27, 2024. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

8 of this board's directors also sit on 18 other boards.

Network of Scholar Rock Holding Corporation's board connections Kalaris Therapeutics Inc. Kalaris Therapeutics I... Adicet Bio Inc. Adicet Bio Inc. Agios Pharmaceuticals Inc. Agios Pharmaceuticals... Alumis Inc. Alumis Inc. Beam Therapeutics Inc. Beam Therapeutics Inc. Boundless Bio Inc. Boundless Bio Inc. CAMP4 Therapeutics Corporation CAMP4 Therapeutics Cor... Disc Medicine Inc. Disc Medicine Inc. Editas Medicine Inc. Editas Medicine Inc. Gossamer Bio Inc. Gossamer Bio Inc. Hemab Therapeutics Holdings Inc. Hemab Therapeutics Hol... InflaRx N.V. InflaRx N.V. Kardigan Inc. Kardigan Inc. Mineralys Therapeutics Inc. Mineralys Therapeutics... Neumora Therapeutics Inc. Neumora Therapeutics I... Seer Inc. Seer Inc. Akshay Vaishnaw Akshay Vaishnaw Amir Nashat Amir Nashat David Hallal David Hallal Jay T. Backstrom Jay T. Backstrom Katie Peng Katie Peng Kristina Burow Kristina Burow Richard Brudnick Richard Brudnick Srinivas Akkaraju Srinivas Akkaraju Scholar Rock Holding Corpo...
Shared director Other board Same sector +2 more in the list below

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$19,988,986
9 purchases by 1 insider
Sold, last 12 months
$19,441,559
38 sales by 13 insiders
Date Insider Transaction Shares Price Value
Sep 24, 2026 Keith Woods Officer (Chief Operating Officer) Gift −48,034 — —
Sep 21, 2026 David Hallal Director, Officer (Chief Executive Officer) Gift −36,652 — —
Jul 1, 2026 Kristina Burow Director Open-market sale −2,105 $53.49 $112,605
Jul 1, 2026 Jeffrey S. Flier Director Open-market sale −1,568 $53.53 $83,939
Jul 1, 2026 Michael Gilman Director Open-market sale −1,346 $53.54 $72,070
Jul 1, 2026 Katie Peng Director Open-market sale −2,988 $53.56 $160,037
Jul 1, 2026 Joshua Reed Director Open-market sale −2,105 $53.50 $112,609
Jul 1, 2026 Kristina Burow Director Open-market sale −948 $54.28 $51,459
Jul 1, 2026 Jeffrey S. Flier Director Open-market sale −1,470 $54.24 $79,728
Jul 1, 2026 Michael Gilman Director Open-market sale −1,155 $54.23 $62,631
Jul 1, 2026 Katie Peng Director Open-market sale −2,437 $54.25 $132,214
Jul 1, 2026 Joshua Reed Director Open-market sale −948 $54.28 $51,459
Jul 1, 2026 Jeffrey S. Flier Director Open-market sale −15 $54.88 $823
Jul 1, 2026 Michael Gilman Director Open-market sale −43 $54.81 $2,357
Jul 1, 2026 Katie Peng Director Open-market sale −21 $54.96 $1,154

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.